Dr. EVRIM KADRIYE TEZCANLI

• 2005Marmara University Faculty of Medicine Radiation Oncology
• 1995 – 2000Istanbul University Istanbul Faculty of Medicine
• 1992 – 1995Gazi Anatolian High School

Experience

• 2020Acıbadem Health Group

• Radiation Oncology Association
• Turkish Oncology Association

• Tolerability and efficacy of temozolomide in high-grade relapsed glaucomaE. Tezcanlı, U. Abacıoğlu, H. Çağlar, PF Yumuk, M. Şengöz, XVI: National Cancer Congress 2005, P106
• Characteristics of patients with nasopharynx tumors who underwent stereotactic radiosurgery after external beam radiotherapyBM Atasoy, E. Tezcanlı, Z. Akgün, S. Peker, U. Abacıoğlu, T. Kılıç, M. Şengöz, N. Pamir, XVI National Cancer Congress 2005, P92
• Chemoradiotherapy results of patients with bladder tumorsI. Cetin, Z. Akgun, H. Caglar, E. Tezcanli, U. Abacioglu, M, Sengoz, F. Yumuk, S. Turhal, XVI. National Cancer Congress 2005, P60
• Prognostic signifiance of MIB-1 labeling indices for oligodendroglial tumorsAbacioglu U, Sengoz M, Tezcanli E, Akbulat S, Peker S, Sav A, Proceedings of ASCO, 122p, Orlando, 2005
• Toxicity and survival outcomes of radiotherapy and concurrent gemcitabine in patients with locally advanced pneumonia.H. Çağlar, U Abacıoğlu, E. Tezcanlı, F. Yumuk, S. Turhal, M. Şengöz, 6th National Radiation Oncology Congress
• Turkish translation and pilot-test study of EORTC colorectal cancer module QLQ-CR 38 in evaluating the quality of life of patients with colorectal cancer, 6th National Radiation Oncology CongressU Abacıoğlu, Ö,.F. Odabaş, E. Tezcanlı, F.Yumuk, H. Çağlar, PF Yumuk, M. Şengöz, S.Tufhal
• Ki-67 proliferation index as a prognostic factor in Glioblastoma MultiformeAbacıoğlu U, Sengoz M, Tezcanlı E, Akbulut S, Peker S, Sav A. Perspective in Central Nervous System Malignanceies, 166, Prague, 2005
• Tolerability and efficacy of temozolomide in high-grade recurrent gliomasU. Abacıoğlu, M. Şengöz, E. Tezcanlı, H. Çağlar, PF Yumuk, 6th National Radiation Oncology Congress, P223